EUVIMEDEUVIMED entdecken
Crossref

Advances and challenges in biosensors for point-of-care detection of Alanine/Aspartate Aminotransferase: A review

Jie Cheng, Yuanyuan Zou, Jinhong Guo

Smart Materials and Devices · 02.11.2026

DOI: 10.70401/smd.2026.0058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Smart Materials and Devices, online erschienen am 02.11.2026. Verfasst von Jie Cheng und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are routinely measured serum biochemical markers used primarily for the assessment of hepatocellular injury and the screening and monitoring of liver diseases. Although ultraviolet-visible spectrophotometry and automatic biochemical analyzers in traditional central laboratories possess high accuracy, they are limited by equipment cost, sample pretreatment and detection duration, and cannot meet the demands of primary healthcare, resource-limited regions, and point-of-care testing (POCT). In recent years, diverse electrochemical, optical, and microfluidic biosensing strategies have been developed for point-of-care aminotransferase detection; this review summarizes these representative advances. It emphatically discusses electrochemical and optical signal transduction mechanisms, deeply analyzes recognition strategies such as oxidase/dehydrogenase cascade reactions, enzyme-free electrode monitoring, and direct capture by high-affinity aptamers, and explores the integrated application of nanomaterials in signal amplification, while stressing that activity-based (U/L) and affinity-based outputs are not interchangeable. Glutamate oxidase and pyruvate oxidase are the most frequently adopted key enzymes in aminotransferase activity detection, and electrochemical biosensors remain the most extensively investigated technology in this field. Distinct from biosensors for metabolites such as glucose and uric acid, aminotransferase biosensors generally require substrate incubation and strict temperature control, which elevates the complexity of miniaturization and point-of-care device development. Paper-based colorimetric sensors provide useful reagent-loading capacity and reaction space, but their POCT readiness still depends on standardized whole-blood handling, reaction control, and clinical validation. This review provides systematic guidance and design strategies for developing next-generation low-cost, portable, and clinically practical aminotransferase POCT diagnostic devices.

Zitieren

APA

Cheng, J., Zou, Y., & Guo, J. (2026). Advances and challenges in biosensors for point-of-care detection of Alanine/Aspartate Aminotransferase: A review. Smart Materials and Devices. https://doi.org/10.70401/smd.2026.0058

Vancouver

Cheng J, Zou Y, Guo J. Advances and challenges in biosensors for point-of-care detection of Alanine/Aspartate Aminotransferase: A review. Smart Materials and Devices. 2026. doi:10.70401/smd.2026.0058

BibTeX
@article{Cheng2026,
  author = {Cheng, Jie and Zou, Yuanyuan and Guo, Jinhong},
  title = {Advances and challenges in biosensors for point-of-care detection of Alanine/Aspartate Aminotransferase: A review},
  journal = {Smart Materials and Devices},
  year = {2026},
  doi = {10.70401/smd.2026.0058}
}
Kostenlos starten →